A retrospective analysis of recurrent intracranial ependymoma

Pediatric Blood and Cancer

Volumn 61, Issue 7, 2014, Pages 1195-1201

  Antony, Reuben ^a   Wong, Kenneth E ^a   Patel, Moneil ^a   Olch, Arthur J ^a   Mccomb, Gordon ^a   Krieger, Mark ^a   Gilles, Floyd ^a   Sposto, Richard ^b   Erdreich Epstein, Anat ^a   Dhall, Girish ^a   Gardner, Sharon ^c   Finlay, Jonathan L ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

Author keywords

Ependymoma; Pediatric; Recurrent

Indexed keywords

CARBOPLATIN; CELECOXIB; CISPLATIN; CYCLOPHOSPHAMIDE; DASATINIB; ERLOTINIB; ETOPOSIDE; GEMCITABINE; IRINOTECAN; LENALIDOMIDE; TEMOZOLOMIDE; THALIDOMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CEREBELLUM TUMOR; CHILD; CLINICAL ARTICLE; EPENDYMOMA; FEMALE; FOLLOW UP; HUMAN; INFANT; INTRACRANIAL EPENDYMOMA; MALE; MEDICAL RECORD REVIEW; NEWBORN; OVERALL SURVIVAL; PRIORITY JOURNAL; SPINAL CORD METASTASIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR RECURRENCE;

EPENDYMOMA; PEDIATRIC; RECURRENT;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EPENDYMOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SPINAL CORD NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 84899666516     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24996     Document Type: Article

References (19)

1. Shim K, Kim D, Choi J, et al. The history of ependymoma management. Childs Nerv Syst 2009; 25:1167-1183.
2. Perilongo G, Massimino M, Sotti G, et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-Oncology Group. Med Pediatr Oncol 1997; 29:79-85.
3. Rezai AR, Woo HH, Lee M, et al. Disseminated ependymomas of the central nervous system. J Neurosurg 1996; 85:618-624.
4. Sutton LN, Goldwein J, Perilongo G, et al. Prognostic factors in childhood ependymomas. Pediatr Neurosurg 1990; 16:57-65.
5. Rousseau P, Habrand JL, Sarrazin D, et al. Treatment of intracranial ependymomas of children: Review of a 15 year experience. Int J Radiat Oncol Biol Phys 1994; 28:381-386.
6. Pollack IF, Gertzen PC, Martinez AJ, et al. Intracranial ependymomas in children: Long term outcome and prognostic factors. Neurosurgery 1995; 37:655-666.
7. Vinchon M, Leblond P, Nodel R, et al. Intracranial ependymomas in childhood: Recurrence, reoperation and outcome. Child Nerv Syst 2005; 21:221-226.
8. Robertson PL, Zeltzer PM, Boyett JM, et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: A report of the Children's Cancer Group. J Neurosurg 1998; 88:695-703.
9. Grill J, Le Deley MC, Gambarelli D, et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age. A multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 2001; 19:1288-1296.
10. Goldwein JW, Glauser TA, Packer RJ, et al. Recurrent Intracranial ependymomas in children. Survival, patterns of failure and prognostic factors. Cancer 1990; 66:557-563.
11. Bouffet E, Hawkins CE, Ballourah W, et al. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation. Int J Radiat Oncol Biol Phys 2012; 83:1541-1548.
12. Evan AE, Anderson JR, Lefkowitz-Boudreaux IB, et al. Adjuvant chemotherapy for childhood posterior fossa ependymoma: Craniospinal irradiation with or without adjuvant CCNU, vincristine and prednisolone: A Children's Cancer Group study. Med Pediatr Oncol 1996; 27:8-14.
13. Mason W, Goldman S, Yates AJ, et al. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma. J Neurooncol 1998; 37:135-143.
14. Bouffet E, Perilongo G, Canete A, et al. Intracranial ependymomas in children: A critical review and plea for co-operation. Med Pediatr Oncol 1998; 30:329-331.
15. Tihan T, Zhou T, Holmes E, et al. The prognostic value of histological grading of posterior fossa ependymomas in children: A Children's Oncology Group Study and a review of prognostic factors. Mod Pathol 2008; 21:165-177.
16. Kilday J, Mitra B, Domerg C, et al. Copy number gain of 1q25 predicts poor progression-Free survival for pediatric intracranial ependymomas and enables patient risk stratification: A prospective European clinical trial cohort analysis on behalf of the Children's Cancer and Leukaemia Group(CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP) and International Society for Pediatric Oncology (SIOP). Clin Cancer Res 2012; 18:2001-2011.
17. Witt H, Mack SC, Ryzhova M, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 2011; 20:143-157.
18. Ernestus RI, Wilcke O, Schroder R. Supratentorial ependymomas in childhood: Clinicopathological findings and prognosis. Acta Neurochir 1991; 111:96-102.
19. Messahel B, Ashley S, Saran F, et al. Relapsed intracranial ependymoma in children in the UK: Patterns of relapse, survival and therapeutic outcome. Eur J Cancer 2009; 45:1815-1823.